Recurrent Alveolar Rhabdomyosarcoma (1)

Recurrent Ewing Sarcoma (1)

Recurrent Lymphoma (1)

Recurrent Malignant Solid Neoplasm (1)

Refractory Alveolar Rhabdomyosarcoma (1)

Refractory Ewing Sarcoma (1)

Refractory Lymphoma (1)

Refractory Malignant Solid Neoplasm (1)

Recruiting (1)

phase 1/phase 2 (1)

National Cancer Institute (NCI) (1)

elimusertib (1)

drug (1)

NIH (1)

Interventional (1)

recurrent alveolar rhabdomyosarcoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jan 26, 2023